Kitazato (368A.T) Osake Kurssi

Kitazato Corp. engages in the manufacturing and sale of medical devices, reagents and related products for infertility treatment. The company is headquartered in Fuji-Shi, Shizuoka-Ken. The company went IPO on 2025-06-25. The firm specializes in reproductive engineering technology in artificial insemination, in vitro fertilization, cell cryopreservation, and regenerative medicine, and manufactures and sells consumables such as medical equipment and reagents that support infertility treatment. The products are mainly research reagents and medical equipment used in vitro fertilization and intracytoplasmic sperm injection. Medical devices related to infertility treatment are divided into media, cryo devices, medical devices, and micro tools. The firm is also involved in the manufacture and sale of medical equipment parts, genetic testing, sale of medical equipment for the elderly, market research and acquisition of local licenses, and contract management of living cells. The company distributes products to markets around the world, including Japan, Europe, the United States, China, and India.